Usefulness of Additional Delayed Regional F-18 Fluorodeoxy-glucose Positron Emission Tomography in the Lymph Node Staging of Non-Small Cell Lung Cancer Patients
Young So, June-Key Chung, Jae Min Jeong, Dong Soo Lee, Myung Chul Lee
Cancer Res Treat. 2005;37(2):114-121.   Published online 2005 Apr 30     DOI:
Citations to this article as recorded by Crossref logo
KSNM60 in Clinical Nuclear Oncology
Seung Hwan Moon, Young Seok Cho, Joon Young Choi
Nuclear Medicine and Molecular Imaging.2021; 55(5): 210.     CrossRef
18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and backgro
Stephen P Povoski, Douglas A Murrey, Sabrina M Smith, Edward W Martin, Nathan C Hall
BMC Cancer.2014;[Epub]     CrossRef
Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapy
Hyun-Cheol Kang, Hong-Gyun Wu, Tosol Yu, Hak Jae Kim, Jin Chul Paeng
Radiation Oncology Journal.2013; 31(3): 111.     CrossRef
Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting
Thomas C. Kwee, Sandip Basu, Drew A. Torigian, Babak Saboury, Abass Alavi
European Journal of Nuclear Medicine and Molecular Imaging.2011; 38(7): 1353.     CrossRef
Imaging Atherosclerosis in the Carotid Arteries with F-18-Fluoro-2-deoxy-D-glucose Positron Emission Tomography: Effect of Imaging Time after Injection on Quantitative Measurement
Minyoung Oh, Ji Young Kim, Kwang-Ho Shin, Seol Hoon Park, Jin-Sook Ryu, Jae Seung Kim, Hye-Jin Kim, Dong-Wha Kang, Dae Hyuk Moon
Nuclear Medicine and Molecular Imaging.2010; 44(4): 261.     CrossRef